TABLE 1

Baseline demographics according to previous treatment

No previous COPD medicationPrevious ICS onlyPrevious LABD onlyPrevious ICS/LABD
Subjects942364317344617
Age years64.764.366.166.0
BMI kg·m−227.528.728.728.6
Females2325 (25%)201 (31%)429 (25%)1231 (27%)
Former smokers4562 (48%)383 (60%)920 (53%)2900 (63%)
Smoking pack-years40.037.843.641.5
Screening FEV1 % predicted60.159.059.858.7
One or more exacerbations3150 (33%)416 (65%)618 (36%)2258 (49%)
Region
 USA1469 (16%)63 (10%)218 (13%)803 (17%)
 Asia#1961 (21%)35 (5%)121 (7%)561 (12%)
 Europe 12139 (23%)88 (14%)1175 (68%)1872 (41%)
 Europe 2+3076 (33%)352 (55%)172 (10%)1025 (22%)
 RoW§778 (8%)105 (16%)48 (3%)356 (8%)

Data are presented as mean, unless otherwise stated. COPD: chronic obstructive pulmonary disease; ICS: inhaled corticosteroids; LABD: long-acting bronchodilators; BMI: body mass index; FEV1: forced expiratory volume in 1 s; RoW: rest of world. #: China, Indonesia, India, Japan, Korea, Malaysia, Philippines, Taiwan, Thailand and Vietnam; : Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Latvia, Netherlands, Poland, Romania, Slovakia, Spain, UK and Croatia; +: Bosnia and Herzegovina, Belarus, Georgia, Israel, Macedonia (Former Yugoslav Republic of), Russian Federation, Serbia, Turkey and Ukraine; §: Argentina, Australia, Canada, Chile, Columbia, Mexico and South Africa.